Inhibition of Immunoglobulin Production in Vitro by IgG and F(ab′)2 Fragments, but not by the Fc Portion

Scandinavian Journal of Immunology

Volumn 43, Issue 5, 1996, Pages 574-582

  Klaesson, S ^a   Tammik, L ^a   Markling, L ^a   Lundkvist, I ^a   Ringden O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; PRIORITY JOURNAL; SPLEEN CELL;

ANTIBODY FORMATION; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; BONE MARROW CELLS; HEMOLYTIC PLAQUE TECHNIQUE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; PEPTIDE FRAGMENTS; SPLEEN;

EID: 0029989107     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-72.x     Document Type: Article

References (29)

1. Immunoglobulin treatment: Mechanisms of action. In: Möller G, ed. Immunological Reviews: Vol. 139. Copenhagen: Munksgaard, 1994.
2. Bussel J, Pahwa S, Porges A et al. Correlation of in vitro antibody synthesis with the outcome of intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. J Clin Immunol 1986;6:50-6.
3. Macey MG, Newland AC. CD4 and CD8 subpopulation changes during high-dose intravenous immunoglobulin treatment. Br J Haematol 1990;76:513-20.
4. Stohl W. Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol 1985;62:200-7.
5. Stohl W, Mayer L. Inhibition of T cell-dependent human B cell proliferation and B cell differentiation by polyspecific monomeric IgG. Clin Exp Immunol 1987;70:649-57.
6. Kondo N, Ozawa T, Mushiake K et al. Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. J Clin Immunol 1991;11:152-8.
7. Kondo N, Kasahara K, Kameyama T et al. Intravenous immunoglobulins suppress immunoglobulin production by suppressing Ca (2+)-dependent signal transduction through Fc gamma receptors in B lymphocytes. Scand J Immunol 1994;40:37-42.
8. Klaesson S, Ringdén O, Markling L, Remberger M, Lundkvist I. Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro. Scand J Immunol 1993;38:477-84.
9. Ringdén O. Induction of immunoglobulin secretion by protein A from Staphylococcus aureus in human blood and bone marrow B cells. Scand J Immunol 1985;22:17-26.
10. Kunori T, Ringdén O. Polyclonal antibody secretion induced in human mixed lymphocyte cultures. Scand J Immunol 1979;10:487-91.
11. Gronowicz E, Coutinho A, Melchers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol 1976;6:588-90.
12. Ringdén O, Rynnel DB, Waterfield EM, Möller E, Möller G. Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol 1977;6:1159-69.
13. Dietrich G, Varela FJ, Hurez V, Bouanani M, Kazatchkine MD. Selection of the expressed B cell repertoire by infusion of normal immunoglobulin G in a patient with autoimmune thyroiditis. Eur J Immunol 1993;23:2945-50.
14. Fridman WH. Regulation of B-cell activation and antigen presentation by Fc receptors. [Review]. Current Opinion in Immunol 1993;5:355-60.
15. Andersson JP, Andersson U. Human intravenous immunoglobulin modulates monokine production in vitro. Immunol 1990; 71:372-6.
16. Toyoda M, Zhang X, Petrosian A, Galera O, Wang S, Jordan S. Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin. J Clin Immunol 1994;14:178-89.
17. Dietrich G, Kaveri SV, Kazatchkine MD. A V region-connected autoreactive subfraction of normal human serum immunoglobulin G. Eur J Immunol 1992;22:170-6.
18. Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993;91:602-7.
19. Marchalonis J, Kaymaz H, Dedeoglu F, Schlutter S, Yocum D, Edmundson A. Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain. Proc Natl Acad Sci 1992;89:332-59.
20. Vassilev T, Gelin C, Kaveri SV, Zilber MT, Boumsell L, Kazatchkine MD. Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Clin Exp Immunol 1993;92:369-72.
21. Blasczyk R, Westhoff U, Grosse WH. Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet 1993;341:789-90.
22. Van Schaik I, Lundkvist I, Vermeulen M, Brand A. Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 1992;12:325-34.
23. Ling ZD, Ziltener HJ, Webb BT, Matheson DS. Aggregated immunoglobulin and Fc fragment of IgG induce IL-6 release from human monocytes. Cellular Immunol 1990;129:95-103.
24. Morgan EL, Hobbs MV, Thoman ML et al. Induction of human B cell differentiation by Fc region activators. II. Stimulation of IL-6 production. J Immunol 1990;144:2499-505.
25. Heyman B. Fc-dependent IgG-mediated suppression of the antibody response: fact or artefact? Scand J Immunol 1990;31:601-7.
26. Hashimoto F, Sakiyama Y, Matsumoto S. The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglobulin production. Clin Exp Immunol 1986;65:409-15.
27. Dai S, Möller G. Antigen-antibody complex-induced immunosuppression. Scand J Immunol 1988;27:413-17.
28. Roux KH, Tankersley DL. A view of the human idiotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-anti-idiotype dimers in pooled human IgG. J Immunol 1990;144:1387-95.
29. Rand KH, Gibbs K, Derendorf H, Graham PJ. Pharmacokinetics of intravenous immunoglobulin (Gammagard) in bone marrow transplant patients. J Clin Pharmacol 1991;31:1151-4.